Why the study?
Does amlodipine improve blood pressure control compared to hydrochlorothiazide in patients with mild to moderate hypertension?
Does amlodipine improve blood pressure control compared to hydrochlorothiazide in patients with mild to moderate hypertension?
Amlodipine and HCTZ showed comparable side effect profiles, but HCTZ was associated with higher rates of blood pressure control (33% vs 26%) at the cost of adverse metabolic effects on cholesterol and potassium.
Answers are grounded in this paper and cite their sources.
Hydrochlorothiazide may be preferred initially over amlodipine for BP control; extends RCT evidence for thiazides while underscoring metabolic monitoring.
In the final analysis of this study at Week 26, 26% of the patients randomized to receive amlodipine attained blood pressure control with amlodipine alone compared with 33% of the patients allocated to hydrochlorothiazide (HCTZ). Neither amlodipine nor HCTZ produced clinically significant changes in pulse rate or in the electrocardiogram. Amlodipine treatment did not appear to produce clinically significant changes in blood lipids; HCTZ, however, produced an increase in total plasma cholesterol (delta 22.9 +/- 8.6 mg/dl). The incidence of side effects and the rate of patient withdrawal in the amlodipine and HCTZ groups were comparable. As expected, HCTZ therapy caused well-recognized biochemical alterations in cholesterol and potassium levels, whereas amlodipine was metabolically neutral.
No takes yet. Share an insight, caveat, or question.
Ram et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: